Scientifically reviewed by Dr Stephan Hansberg
Peptide net content vs purity: why 99% isn't 99% by mass
What net peptide content means, how counter-ions such as TFA and acetate and absorbed water reduce the peptide share of a powder, and how a measured mg/ml result relates to the label claim.
Key takeaways
- •Purity is the share of UV-detected material that is the target peptide. Net peptide content is the share of the total weighed mass that is peptide.
- •A lyophilised peptide powder also contains counter-ions (TFA, acetate or chloride) and water, so its net peptide content is commonly well below 100%.
- •A 1000 Da peptide carrying two TFA counter-ions has a theoretical maximum net content of about 81% before any water is counted.
- •A measured mg/ml or mg-per-vial result, calibrated against a reference standard, is the figure to compare with the label claim.
- •For a pre-mixed solution the label claim is a concentration; Celyfe's pens state exact mg per 3ml cartridge.
The short answer
A peptide that is 99% pure by HPLC is not 99% peptide by weight. HPLC purity only compares the target with other UV-absorbing material, while a weighed powder also contains counter-ions left from synthesis and purification, such as trifluoroacetate (TFA) or acetate, plus absorbed water. The share of the weighed mass that is actually peptide is the net peptide content, and published supplier data put it typically somewhere between about 60% and 90%.
What net peptide content means
When a lyophilised peptide is weighed, the balance records everything in the vial: the target peptide, peptide-related impurities, counter-ions bound to charged groups, and water. Net peptide content is the peptide fraction of that gross weight. GenScript's technical material describes a mass balance in which target peptide, peptidic impurities, counter-ion and water should add up to 100%.
Net peptide content is usually measured by amino acid analysis (hydrolysing the peptide and quantifying the amino acids) or by nitrogen elemental analysis, which works because common counter-ions and water contain no nitrogen. Counter-ion content can be measured separately by ion chromatography, and water by Karl Fischer titration.
| Component of a weighed powder | Counted in HPLC purity? | Counted in net peptide content? | Typical measurement |
|---|---|---|---|
| Target peptide | Yes (main peak) | Yes | HPLC, amino acid analysis |
| Peptide-related impurities (deletions, truncations) | Yes (minor peaks) | Yes, as peptide material | HPLC, LC-MS |
| Counter-ions (TFA, acetate, chloride) | No | No | Ion chromatography |
| Water | No | No | Karl Fischer titration |
Counter-ions: TFA and acetate
Peptides are usually cleaved from the synthesis resin and purified using trifluoroacetic acid, a strong acid. Positively charged groups on the peptide (the N-terminus and side chains of lysine, arginine and histidine) pair with trifluoroacetate anions, and the purified peptide is often supplied as a TFA salt. Many manufacturers offer an ion exchange to the acetate or hydrochloride salt.
Counter-ions add mass. In a worked example from supplier literature, a peptide of 1000 Da with two TFA salt sites (about 114 Da each) has a theoretical net content of 1000 / 1228, about 81%, before any water. Acetate is lighter, so an acetate salt of the same peptide has a higher theoretical net content. Salt form also matters experimentally: a 1999 study reported that trifluoroacetate inhibited proliferation of osteoblast and chondrocyte cell cultures, one reason some cell researchers specify acetate or chloride salts.
Water content
Lyophilised peptides are often hygroscopic, which means they take up moisture from the air. Water content therefore depends on the drying process, packaging and how often the vial has been opened, and it can change over time. This is one reason a powder's apparent mass is an unreliable proxy for the amount of peptide present.
Why 99% purity is not 99% peptide by mass
Combine the two measures and the gap becomes clear. Take a 10mg vial of powder with 99% HPLC purity and 75% net peptide content. About 7.5mg of the powder is peptide material, and about 99% of that peptide material is the target, so roughly 7.4mg of target peptide is present. Both numbers on the certificate are correct; they measure different things.
Labels in the research market are not always clear about which basis is used. Some state gross powder weight, some state peptide content. A quantity result on a certificate, expressed in mg of peptide, removes the ambiguity.
How a measured mg/ml result relates to the label
For solutions, the question becomes concentration. A laboratory measures it by running the sample through quantitative HPLC and comparing the signal with a calibration curve made from a reference standard of known concentration. The result is reported as mg/ml, or as a percentage of the label claim.
To compare it with the label, divide the labelled total by the labelled volume. A 3ml cartridge labelled 15mg of a peptide has a nominal concentration of 5mg/ml; a measured 4.8mg/ml would be 96% of label. When reading such a result, check whether the reference standard's own salt form and water content were corrected for, since that determines whether the figure means mg of free peptide or mg of salt.
Powder labels versus solution labels
The net content problem is mainly a powder problem. When a supplier fills a vial with lyophilised material, the label figure may refer to the gross weight of powder dispensed or to the calculated amount of peptide, and the two can differ by a quarter or more. Without a quantity result on the certificate, a reader cannot tell which basis was used.
With a solution, the relevant figure is concentration, and it can be measured directly by quantitative HPLC against a reference standard. Water is no longer a hidden variable because the material is already in solution, although the salt form of the peptide still determines whether a concentration refers to free peptide or to its salt. Solutions bring their own questions instead, chiefly stability over time and storage temperature, which is why refrigerated storage and cold-chain shipping matter for pre-mixed formats.
Whichever format is involved, the checklist is the same: what does the label claim, on what basis, and is there a measured result for this batch that can be compared with it?
Where Celyfe fits
Celyfe pens are supplied as pre-mixed solutions, so the label states exact mg per 3ml cartridge rather than a powder weight. The nominal concentrations follow directly from the label.
| Pen | Labelled content per 3ml | Nominal concentration | Published COA |
|---|---|---|---|
| NAD+ Precision Pen | NAD+ 500mg | 166.7mg/ml | Batch A26085, 99% HPLC purity (Analiza Białek, 2 Oct 2026) |
| WOLVERINE | BPC-157 15mg + TB-500 15mg | 5mg/ml each | Batch C26071, 99% HPLC purity (Analiza Białek, 2 Oct 2026) |
| GLOW | GHK-Cu 75mg + BPC-157 15mg + TB-500 15mg | 25mg/ml GHK-Cu; 5mg/ml each other | Being re-issued; listed at /coa when published |
| KLOW | GLOW + KPV 15mg | As GLOW, plus 5mg/ml KPV | Being re-issued; listed at /coa when published |
Sources
Sources used for this guide, checked October 2026:
- GenScript: Examining the components of your peptide sample with AccuPep QC (technical presentation)
- GenScript: Avoiding peptide assay failure, hidden problems and solutions (technical note)
- Cornish J et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol, November 1999. PMID 10567002
- Finnrick: How to read a certificate of analysis (COA), 1 March 2026
- Celyfe product labels and COA library (/coa), October 2026
Research use only
Celyfe supplies research peptides for laboratory and research use only. Nothing on this page is guidance on use in humans or animals.
Research updates
Peptide research and testing, in your inbox
New batch certificates, regulation changes and a monthly digest of new published research on the compounds we cover. No spam, unsubscribe at any time.


